Navigation Links
Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference
Date:6/24/2008

Presentation Scheduled for Thursday, June 26th at 2:30pm ET

NEW YORK, June 24 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Michael S. Weiss, the Company's Chairman and Chief Executive Officer, is scheduled to present at the Jefferies & Co. Healthcare Conference being held in New York City.

Mr. Weiss' presentation will be webcast live on Thursday, June 26th at 2:30pm ET and will be accessible from the Investor Information page of the Company's Website at http://investors.keryx.com. An archived version of the webcast will be available following the conclusion of the live presentation.

ABOUT KERYX BIOPHARMACEUTICALS, INC.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including renal disease and cancer. Keryx is developing Zerenex(TM) (ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Zerenex is currently in Phase 2 clinical development for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease, or ESRD. The Company is also developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that modulates Akt, a protein in the body associated with tumor survival and growth. KRX-0401 also modulates a number of other key signal transduction pathways, including the JNK and MAPK pathways, which are pathways associated with programmed cell death, cell growth, cell differentiation and cell survival. KRX-0401 is currently in Ph
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
2. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on First Quarter 2008 Financial Results on Monday, May 12, at 8:30 A.M. EDT
3. Keryx Biopharmaceuticals to Present at the Deutsche Bank 33rd Annual Health Care Conference
4. Keryx Biopharmaceuticals Receives Nasdaq Notification
5. Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan
6. Keryx Biopharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference
7. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
8. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
10. Keryx Biopharmaceuticals Announces Additions to Management Team
11. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...5/PRNewswire/--Formanybusinesses,2009hasbeenapainf...stestgrowingnetworkofexpertphysiciansspecializinge...es has grownthenumberof physiciansinitsnetwork ...ogresstoaddmorephysician-ownedcenters,includingone...ar ,BodyLogicMDhasopened13newbioidenticalhormonesp...
(Date:11/24/2009)...an . , Whether it,s CD packaging, containers...cy Identification) are increasingly finding their ...abel objects or goods and identify them automatica...n read and process the data contained in the label...ction conditions of up to 100 degrees Celsius. But...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--DowAgroSciencesCanadaa...divisionofThompsonsLimitedofBlenheim,Ontario.Thead...s,currentseedsbusinessasthecompanyanticipatesthein...encesHerbicideTolerantTraitTechnologyincornin2012...., "Thisacquisitionbringstogethertwostrongprogres...
(Date:11/24/2009)...ia/--NODPharmaceuticalsInc.announced,theUSPatent&a...ionfor,itsnano-particleoraldeliveryorNODtechnology...incorporatepeptidesor,proteinsintobio-adhesivenano...inisteredasinjections.NODtechnologyisaplatformtech...chasinsulin,interferon,growthhormone,exenatide,he...
Breaking Biology Technology:Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Intelligence inside metal components 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...ting meeting took place this past week at the Univ...hicago Technology Forum. The focus of the meeting ...who have been intimately involved in the last annu...to what we might expect or should prepare for when...hicago in April, 2006. , ,Some Chicagoans have lik...
... has launched a pilot program for one Fitchburg ne...as high as 10 megabits per secondseveral times hig...tly availablein order to gauge customer usage and ..., ,With whats going on with the Internet today, we...ster speeds, said TDS marketing manager Michele Fa...
...enome Atlas is intented to be for cancers what the...ill let scientists better distinguish different ty...treatments that are more likely to work on patient...l treatment plans. , ,National agencies are starti...ral money over the next three years to study a sam...
Other Biology Technology:The legacy of BIO 2006, what it will be and how we need to plan for it now 2The legacy of BIO 2006, what it will be and how we need to plan for it now 3The legacy of BIO 2006, what it will be and how we need to plan for it now 4The legacy of BIO 2006, what it will be and how we need to plan for it now 5The legacy of BIO 2006, what it will be and how we need to plan for it now 6TDS tries bringing fiber to homes in Fitchburg for faster Internet service 2TDS tries bringing fiber to homes in Fitchburg for faster Internet service 3
(Date:11/23/2009)... TORONTO, November 23, 2009 - The time of day matt...g to a new paper produced by a research team led b...o Scarborough,s vice-principal for research and co...logy at the St. George campus. , Capitalizing ... poplar tree, the research team examined how popla...
(Date:11/23/2009)...armington, CT Current research suggests that a co...ase. The related report by Nichols et al, "Unique...New Class of TLR2 Ligands Capable of Enhancing Aut...The American Journal of Pathology . , Multiple ...attacks the brain and spinal cord, affects nearly ...
(Date:11/23/2009)...IVERMORE, Calif. - By producing some of the highes...al surfaces, scientists have a deeper understandin... This research may lead to a new treatment for kid...hich appears in the Nov. 23 online edition of the ...iences , explores how peptides interact with miner...
Breaking Biology News(10 mins):Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Two Powerful Companies One Powerhouse in Protection 55790 1Two Powerful Companies One Powerhouse in Protection 55790 2Stemedica Achieves Major Milestone Company Receives License to Manufacture Clinical Grade Stem Cells 4924 1Stemedica Achieves Major Milestone Company Receives License to Manufacture Clinical Grade Stem Cells 4924 2Shifting baselines confound river restoration 9746 1Shifting baselines confound river restoration 9746 2
...searchers from the University of Alberta, the Yerk...rsity and the Emory Transplant Center has successf...ne islet cells into monkeys, a procedure the resea...ution to the critical supply problem in clinical i... A and Emory, along with recent work at the Univer...
...at the University of Pennsylvania School of Medici...ed Vpr destroys the host cell,s ability to survive...ps an important enzyme from activating the cell,s ...derstanding of Vpr HIV pathogenesis and imply new ... such as rheumatoid arthritis, and possibly sepsis...
...ticular cartilage (cartilage covering the ends of ...s due to injury or illness, and can lead to degene...ches to repair this articular cartilage have achie...hod to fully restore this type of injured cartilag...erapeutic proteins to the injured site is a promis...
Other Biology News:Diabetes researchers pioneer islet cell xenotransplantation in primate studies 2HIV accessory protein disables host immunity via receptor-protein intermediary 2Stem cells from muscles can repair cartilage 2Stem cells from muscles can repair cartilage 3
...l to BRF2 Immunogen Synthetic peptide: QAARQAATS...-419 of Human BRF2. Reactivity / Specificity Cro...ies. Background Information BRF2 is one of the m...iption factor complex required for transcription o...
Kinase Buffer (10X) from Cell Signaling Technology
Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Biology Products: